MELD-Na: Does This Leave Anyone Behind?

MELD-Na: Does This Leave Anyone Behind? Curr Hepatology Rep (2017) 16:220–227 DOI 10.1007/s11901-017-0356-8 MANAGEMENT OF THE CIRRHOTIC PATIENT (A CARDENAS AND N REAU, SECTION EDITORS) 1 2 Tenzin Choden & Rohit Satoskar Published online: 22 July 2017 Springer Science+Business Media, LLC 2017 Abstract on a regional level, prompting the proposal for a national Purpose of Review This article reviews the historical evolu- review board. tion of the current deceased donor liver allocation and distri- bution policy in the USA and describes the continued efforts . . . . to address limitations within our current allocation system. Keywords MELD MELD-Na Frailty Liver transplant Recent Findings Due to the finding that hyponatremia is an National review board independent predictor of mortality, since January 2016, the Model for End-stage Liver Disease (MELD)-Na score incor- porating serum sodium is now used for patients with MELD score <11. MELD exception points allocation continues to be Introduction a challenging prospect in hepatocellular carcinoma (HCC); new changes include a “delay and cap” policy implemented Starzl and colleagues performed the first human liver trans- in 2015 but consideration of other HCC-specific MELD plantation in 1963 [1]. Due to poor outcomes, a worldwide scores are being explored. In order to address the significant moratorium http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Hepatology Reports Springer Journals

MELD-Na: Does This Leave Anyone Behind?

Loading next page...
 
/lp/springer_journal/meld-na-does-this-leave-anyone-behind-Og6uAa93ZG
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Hepatology
eISSN
2195-9595
D.O.I.
10.1007/s11901-017-0356-8
Publisher site
See Article on Publisher Site

Abstract

Curr Hepatology Rep (2017) 16:220–227 DOI 10.1007/s11901-017-0356-8 MANAGEMENT OF THE CIRRHOTIC PATIENT (A CARDENAS AND N REAU, SECTION EDITORS) 1 2 Tenzin Choden & Rohit Satoskar Published online: 22 July 2017 Springer Science+Business Media, LLC 2017 Abstract on a regional level, prompting the proposal for a national Purpose of Review This article reviews the historical evolu- review board. tion of the current deceased donor liver allocation and distri- bution policy in the USA and describes the continued efforts . . . . to address limitations within our current allocation system. Keywords MELD MELD-Na Frailty Liver transplant Recent Findings Due to the finding that hyponatremia is an National review board independent predictor of mortality, since January 2016, the Model for End-stage Liver Disease (MELD)-Na score incor- porating serum sodium is now used for patients with MELD score <11. MELD exception points allocation continues to be Introduction a challenging prospect in hepatocellular carcinoma (HCC); new changes include a “delay and cap” policy implemented Starzl and colleagues performed the first human liver trans- in 2015 but consideration of other HCC-specific MELD plantation in 1963 [1]. Due to poor outcomes, a worldwide scores are being explored. In order to address the significant moratorium

Journal

Current Hepatology ReportsSpringer Journals

Published: Jul 22, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off